GlaxoSmithKline's Witty Plays Down Impact Of U.S. Health Care Reform

03 May 2010

• By The Pink Sheet

Health care reform in the U.S. will not have a significant impact on GlaxoSmithKline's performance in 2010, the company's CEO Andrew Witty told analysts during a first-quarter earnings call on April 28

GlaxoSmithKline's Witty Plays Down Impact Of U.S. Health Care Reform

More from Archive

More from Pink Sheet